What is the clinical evidence from this study?

Study design: Review. Population: Acute Coronary Syndromes and Heart Failure.

March 23, 2007Clinical ChemistryOpen Access

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Utilization of Biochemical Markers in Acute Coronary Syndromes and Heart Failure

View Full Paper

Ask AI

Bookmark

Population

Patients with Acute Coronary Syndromes (ACS) and Heart Failure

Design

Guideline

Authors

RCRobert H. ChristensonGeneral Cardiology

Discussion

Member takes

Implication

Updated guidelines now direct biomarker use in ACS and HF; extends prior recommendations with current evidence synthesis.

Structured PICO

Population

Patients with Acute Coronary Syndromes (ACS) and Heart Failure

Intervention

Utilization of biochemical markers

This document provides updated NACB laboratory medicine practice guidelines for the clinical utilization and analytical issues of biochemical markers in ACS and heart failure.

Cite This Study

Robert H. Christenson (2007) conducted a review in Acute Coronary Syndromes and Heart Failure. The NACB developed updated Laboratory Medicine Practice Guidelines for the utilization of biochemical markers in acute coronary syndromes and heart failure.

synapsesocial.com/papers/6a5eafab3b1677c8bf06669a https://doi.org/10.1373/clinchem.2006.079749

View Full Paper

Ask AI

Bookmark

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Utilization of Biochemical Markers in Acute Coronary Syndromes and Heart Failure

Discussion

Member takes

Implication

Structured PICO

Cite This Study

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Utilization of Biochemical Markers in Acute Coronary Syndromes and Heart Failure

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider